According to Zhitong Finance App, Hengrui Pharmaceutical (01276.HK) issued an announcement. In July 2026, the company repurchased 280,000 shares through the Shanghai Stock Exchange trading system. The repurchased shares accounted for 0.004% of the company's total share capital. The highest purchase price was RMB 54.05 per share, the lowest price was RMB 53.75 per share, and the total amount paid was RMB 1,50888 million (excluding transaction fees).

According to Zhitong Finance App, Hengrui Pharmaceutical (01276.HK) issued an announcement. In July 2026, the company repurchased 280,000 shares through the Shanghai Stock Exchange trading system. The repurchased shares accounted for 0.004% of the company's total share capital. The highest purchase price was RMB 54.05 per share, the lowest price was RMB 53.75 per share, and the total amount paid was RMB 1,50888 million (excluding transaction fees).